Zai Lab to Highlight New Data from its Oncology Pipeline at 2023 ASCO Annual Meeting Three poster presentations to provide updates on Zai Lab’s oncology programs focused on unresectable solid tumors, ovarian cancer and gastrointestinal stromal tumors Early Phase 1/2 study data from...